Rituximab Therapy for Refractory Scleritis

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

Stanley Cohen, Paul Emery, Maria Greenwald et al. · Arthritis & Rheumatism · 2006 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +16

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double‐blind, placebo‐controlled trial

J Meijer, P. Meiners, Arjan Vissink et al. · Arthritis & Rheumatism · 2010 · 490 citations

Medicine, Immunology, Internal Medicine +16

Episcleritis and scleritis: clinical features and treatment results

Douglas A. Jabs, Abdulbaki Mudun, James P. Dunn et al. · American Journal of Ophthalmology · 2000 · 389 citations

Medicine, Pathobiology, Inflammation +8

Evaluation of patients with scleritis for systemic disease

Esen K. Akpek · Ophthalmology · 2004 · 293 citations

Medicine, Internal Medicine, Autoimmunity +8